Chronic Liver Disease
Iron overload is rare in liver disease patients in Turkey
Published in Hepatitis Weekly, July 11th, 2005
"Our objective was to determine the effect of serum iron levels and hepatic iron overload on hepatocellular damage in nonalcoholic steatohepatitis (NASH) and to compare this with chronic viral hepatitis. Twenty-five patients who had elevated transaminase levels on at least two occasions, without any evidence of viral and autoimmune hepatitis and diabetes, without a history of significant alcohol use, and with a liver biopsy consistent with NASH were enrolled in the study," investigators in Turkey report.
"Twenty-five patients with chronic viral hepatitis (13 patients with chronic hepatitis C...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-07-11)
More Articles from Hepatitis Weekly
- Diagnostics
Doppler sonography is unreliable for grading chronic liver disease - Diagnostics
Hepatitis D assay tracks virological response to interferon - Hepatitis B Therapy
Some patients with hepatitis B mutations profit from prolonged lamivudine - Renal Disease
Laser capture microdissection measures hepatitis C in renal tissues - Stem Cell Research
Recipients of hepatitis B-positive stem cells need antiviral prophylaxis - Antiviral Therapy
Researchers' data advance antiviral therapy research - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
